This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
PEACE-3 Trial
PROfound Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
VISION Trial
mHSPC
ARANOTE Trial
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA Trial
CONDOR Trial
OSPREY Trial
Bladder Cancer
ANKTIVA
Bladder Cancer Detection
CORE-001 Study
EV-302
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Decipher® Genomic Classifier
Imaging Center
Phillip Koo, MD
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
mCRPC Treatment
A. Oliver Sartor, MD
mCRPC with Bone Metastasis
PSMA-Targeted Therapy
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular Cancer
Pelvic Health & Reconstruction
Bladder Health
Urologic Catheters (Includes CAUTI)
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Actionable Clinical Data
Bladder Cancer
LG-IR NMIBC
Adstiladrin®
Kidney Cancer
ZIRCON
Trials in Progress
Trials in Progress
Bladder Cancer
BOND-003 Cohort P
CORE-008
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
UCLA-UCSF-PCF PSMA 2025
EAU 2025
SES AUA 2025
Thought Leaders 2025
APCCC Diagnostics 2025
All Conferences
View All
Quick Takes
ESMO 2024
PCF
UroToday Home
Recent Abstracts
Urologic Oncology
Bladder Cancer
Conferences
Recent Abstracts
ICS 2013 - Podcast: Stephen R. Kraus, MD, FACS discusses highlights of the urodynamics sessions from the Annual Scientific Meeting of the International Continence Society
September 6, 2013
ICS 2013 - Podcast: Stephen R. Kraus, MD, FACS discusses highlights of the urodynamics sessions from the Annual Scientific Meeting of the International Continence Society
September 6, 2013
ICS 2013 - Abstract: A prospective randomised controlled multicentre trial comparing intravesical DMSO and chondroitin sulphate 2 for painful bladder syndrome/interstitial cystitis
September 4, 2013
ICS 2013 - Abstract: A prospective randomised controlled multicentre trial comparing intravesical DMSO and chondroitin sulphate 2 for painful bladder syndrome/interstitial cystitis
September 4, 2013
ICS 2013 - Podcast: Christopher K. Payne, MD, FACS discusses highlights of the bladder pain/interstitial cystitis sessions from the Annual Scientific Meeting of the International Continence Society
September 4, 2013
ICS 2013 - Podcast: Christopher K. Payne, MD, FACS discusses highlights of the bladder pain/interstitial cystitis sessions from the Annual Scientific Meeting of the International Continence Society
September 4, 2013
ICS 2013 - Abstract: Combination treatment with mirabegron and solifenacin in patients with overactive bladder (OAB) – efficacy and safety results from a randomised phase II study (SYMPHONY)
September 3, 2013
ICS 2013 - Abstract: Combination treatment with mirabegron and solifenacin in patients with overactive bladder (OAB) – efficacy and safety results from a randomised phase II study (SYMPHONY)
September 3, 2013
ICS 2013 - Abstract: The antidiuretic effect of fedovapagon can be effectively controlled by dose
September 3, 2013
ICS 2013 - Abstract: The antidiuretic effect of fedovapagon can be effectively controlled by dose
September 3, 2013
ICS 2013 - Abstract: Development of a short-form for evaluating the pathophysiologic mechanisms of nocturia
September 3, 2013
ICS 2013 - Abstract: Development of a short-form for evaluating the pathophysiologic mechanisms of nocturia
September 3, 2013
ICS 2013 - Podcast: Kari Tikkinen, MD, PhD discusses highlights of the overactive bladder and nocturia sessions from the Annual Scientific Meeting of the International Continence Society
September 3, 2013
ICS 2013 - Podcast: Kari Tikkinen, MD, PhD discusses highlights of the overactive bladder and nocturia sessions from the Annual Scientific Meeting of the International Continence Society
September 3, 2013
CUA 2013 - Session Highlights: Impact of enzalutamide on time to first skeletal related event (SRE) and pain in the phase III AFFIRM study
June 27, 2013
CUA 2013 - Session Highlights: OnabotulinumtoxinA (onabotA) in patients with overactive bladder (OAB) and urinary incontinence (UI): Consistent effect over repeat treatment
June 27, 2013
CUA 2013 - Slide Presentation: Current controversies in prostate cancer management
June 25, 2013
CUA 2013 - Slide Presentation: Final analysis of intergroup (NCIC-CTG, CUOG, SWOG, MRC-UK) randomized phase III study of androgen deprivation therapy (ADT) and radiation therapy (RT) in locally advanced prostate cancer
June 25, 2013
CUA 2013 - Session Highlights: Final analysis of intergroup (NCIC-CTG, CUOG, SWOG, MRC-UK) randomized phase III study of androgen deprivation therapy (ADT) and radiation therapy (RT) in locally advanced prostate cancer
June 25, 2013
CUA 2013 - Session Highlights: The association between finasteride use and high-grade or lethal prostate cancer
June 25, 2013
Page 579 of 614
Start
Prev
574
575
576
577
578
579
580
581
582
583
Next
End
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free